Do proteolytic enzymes affect the development of idiopathic pulmonary fibrosis. - Vienna 2024

Pathogenesis of pulmonary fibrosis and serum biomarkers

Chair(s): ARGYRIS TZOUVELEKIS, Raquel Guillamat Prats

Session type: Poster session

Do proteolytic enzymes affect the development of idiopathic pulmonary fibrosis.

Oksana Karasova

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Multifaceted analysis of serum biomarkers for autoimmune features in patients with idiopathic interstitial pneumonia: A post-hoc analysis of prospective multicenter cohort study

Noriyuki Enomoto

Poster

Abstract

Unravelling the role of sFRP2 in the pathogenesis of Idiopathic Pulmonary Fibrosis

Ioannis Tomos

Poster

Abstract

Clinical usefulness of serum KL-6 and SP-A levels as biomarkers of pulmonary fibrosis in healthy subjects

Eun-jung Cho

Poster

Abstract

Chemerin: a novel player in lung fibrosis

Ani Garabet

Poster

Abstract

Do proteolytic enzymes affect the development of idiopathic pulmonary fibrosis.

Oksana Karasova

Poster

Abstract

Suppression of Macrophage Migration Inhibitory Factor Attenuates Pulmonary Fibrosis by Regulating Macrophage-Fibroblast Interactions via AKT, AMPK, and ERK Pathways

Jingwei Wang

Abstract

Analyzing the variance in protein expression profiles between patients diagnosed with idiopathic pulmonary fibrosis (IPF) and those with non-IPF interstitial lung diseases (ILD)

Pin-kuei Fu

Poster

Abstract

Adiponectin expression in fibrotic interstitial lung diseases: a case-control study

Vito D'agnano

Poster

Abstract

Role of hypusine signaling in idiopathic pulmonary fibrosis

Sarah-eve Lemay

Poster

Abstract

Repetitive installations of bleomycin induce persistent progressive lung fibrosis in a mouse model of IPF

Jamal Bousamaki

Poster

Abstract

Identification of Biomarkers by Multiplex Suspension Array to Predict Progression in Patients with Idiopathic Interstitial Pneumonias

Masaki Okamoto

Poster

Abstract

Extracellular matrix remodeling biomarkers in patients with hypersensitivity pneumonitis, compared with idiopathic pulmonary fibrosis and healthy controls

Sandra Duval Dr?by

Abstract

Post-hoc biomarker analysis in participants with IPF receiving bexotegrast over 12-weeks in INTEGRIS-IPF

Martin Decaris

Poster

Abstract

Lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis

Gabriel Escarrer-garau

Poster

Abstract

A marker of human neutrophil elastase mediated club cell secretory protein-16 degradation (CC16-HNE) is associated with mortality and pulmonary hypertension in idiopathic pulmonary fibrosis

Annika Hummersgaard Hansen

Poster

Abstract

Factor XII Deregulates Cell Communication and Contributes to Progression of Lung Fibrosis

Malgorzata Wygrecka

Abstract

DTAI ameliorated acute lung injury and pulmonary fibrosis by suppressing the TGF-?/Smad signaling pathway in mice

Wei-chung Chiou

Poster

Abstract

Biomarkers of fibrotic interstitial pneumonia with antifibrotic agent treatment

Takashi Maeda

Poster

Abstract

Development of a multi-biomarker risk score based on serum proteins by the Prognostic Lung Fibrosis Consortium (PROLIFIC)

Joseph Lasky

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}